Avastin⢠(bevacizumab; anti-VEGF antibody in phase III clinical trials with
Xeloda for metastatic breast CA by Genentech; also found to be excellent for colorectal cancer; stops new red cells from forming cancer cells and also being used in studies for hepatocellular carcinoma, FDA approved 2/04)